L.F. van der Voort

773 total citations
6 papers, 613 citations indexed

About

L.F. van der Voort is a scholar working on Pathology and Forensic Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L.F. van der Voort has authored 6 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 3 papers in Oncology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L.F. van der Voort's work include Multiple Sclerosis Research Studies (6 papers), Viral Infections and Immunology Research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). L.F. van der Voort is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Viral Infections and Immunology Research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). L.F. van der Voort collaborates with scholars based in Netherlands, United States and Italy. L.F. van der Voort's co-authors include Chris H. Polman, Joep Killestein, Franklin L. Zhong, Brigit A. de Jong, May Han, Chander Raman, Ilan Kolkowitz, Robert C. Axtell, Lawrence Steinman and Rodrigo Naves and has published in prestigious journals such as Nature Medicine, PLoS ONE and Neurology.

In The Last Decade

L.F. van der Voort

6 papers receiving 602 citations

Peers

Countries citing papers authored by L.F. van der Voort

Since Specialization

Citations

This map shows the geographic impact of L.F. van der Voort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L.F. van der Voort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L.F. van der Voort more than expected).

Fields of papers citing papers by L.F. van der Voort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L.F. van der Voort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L.F. van der Voort. The network helps show where L.F. van der Voort may publish in the future.

Co-authorship network of co-authors of L.F. van der Voort

This figure shows the co-authorship network connecting the top 25 collaborators of L.F. van der Voort. A scholar is included among the top collaborators of L.F. van der Voort based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L.F. van der Voort. L.F. van der Voort is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonβ therapy in multiple sclerosis 2011 ·Genes and Immunity ·Saskia Vosslamber, L.F. van der Voort, (unknown), Roel Heijmans, Cristin Aubin, Bernard M.J. Uitdehaag, J. Bart A. Crusius, (unknown), Manuel Comabella, Xavier Montalbán, David A. Hafler, Philip L. De Jager, Joep Killestein, Chris H. Polman, C L Verweij	25
2	T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis 2010 ·Nature Medicine ·Robert C. Axtell, Brigit A. de Jong, Katia Boniface, L.F. van der Voort, R. Bhat, Patrizia De Sarno, Rodrigo Naves, May Han, Franklin L. Zhong, Jim G. Castellanos, Robert D. Mair, (unknown), Ilan Kolkowitz, (unknown), Joep Killestein, Chris H. Polman, René de Waal Malefyt, Lawrence Steinman, Chander Raman	425
3	Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosis 2010 ·Archives of Neurology ·L.F. van der Voort	25
4	Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS 2010 ·Neurology ·L.F. van der Voort, Anke Vennegoor, Allerdien Visser, Dirk L. Knol, Bernard M.J. Uitdehaag, Frederik Barkhof, Cees B.M. Oudejans, Chris H. Polman, Joep Killestein	31
5	Lack of interferon‐beta bioactivity is associated with the occurrence of relapses in multiple sclerosis 2009 ·European Journal of Neurology ·L.F. van der Voort, Allerdien Visser, Dirk L. Knol, Cees B.M. Oudejans, Chris H. Polman, Joep Killestein	18
6	Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients 2008 ·PLoS ONE ·Lisa G. M. van Baarsen, Saskia Vosslamber, Marianne Tijssen, Josefien M. Baggen, L.F. van der Voort, Joep Killestein, Tineke C. T. M. van der Pouw Kraan, Chris H. Polman, Cornelis L. Verweij	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact